avatar

AULIYA ABDURROHIM SUWANTIKA

Universitas Padjadjaran S2 - Farmasi Klinik SINTA ID : 6082843
3.059
SINTA Score Overall
619
SINTA Score 3Yr
0
Affil Score
0
Affil Score 3Yr
Latest number of activities
ANALISIS EFEKTIVITAS BIAYA INTERVENSI KESEHATAN BARU DI INDONESIA: STUDI KASUS PROGRAM VAKSINASI, NUTRISI, DAN INTERVENSI KESEHATAN DIGITAL
Leader : Auliya Abdurrohim Suwantika ALG ( ALG )
Personils : Restuning Widiasih;
2024 Rp. 100,000,000.00 Approved
SETTING PRIORITIES FOR NEW HEALTHCARE INTERVENTIONS IN LOW- AND MIDDLE-INCOME COUNTRIES
Leader : Auliya Abdurrohim Suwantika BPDP ( BPDP )
Personils : Neily Zakiyah;
2024 Rp. 30,000,000.00 Approved
ANALISIS UTILITAS BIAYA TERAPI HIPERTENSI DI JAWA BARAT
Leader : Auliya Abdurrohim Suwantika BUPP ( BUPP )
Personils : Neily Zakiyah;
2024 Rp. 30,000,000.00 Approved
ANALISIS EFEKTIVITAS BIAYA PENGOBATAN HIPERTENSI DI KOTA BANDUNG
Leader : Auliya Abdurrohim Suwantika RDDU ( RDDU )
Personils : -
2024 Rp. 60,000,000.00 Approved
EVALUSI PERFORMA PROGRAM IMUNISASI RUTIN SEBELUM DAN SESUDAH PANDEMI COVID-19 PADA DAERAH RURAL DAN URBAN DI PROVINSI JAWA BARAT
Leader : Auliya Abdurrohim Suwantika RKDU ( RKDU )
Personils : Neily Zakiyah;
2023 Rp. 60,000,000.00 Approved
ANALISIS EFEKTIVITAS BIAYA PENGOBATAN HIPERTENSI DI KOTA BANDUNG
Leader : Auliya Abdurrohim Suwantika RDDU ( RDDU )
Personils : Melisa Intan Barliana;
2023 Rp. 60,000,000.00 Approved
ANALISIS UTILITAS BIAYA TERAPI HIPERTENSI DI JAWA BARAT
Leader : Auliya Abdurrohim Suwantika BUPP ( BUPP )
Personils : -
2023 Rp. 30,000,000.00 Approved
HYPERTENSION DISORDERS IN PREGNANCY AND RISK OF CARDIOVASCULAR DISEASES: DRUG EVALUATION AND COST ANALYSIS
Leader : Neily Zakiyah RPLK ( RPLK )
Personils : Auliya Abdurrohim Suwantika; Fredrick Dermawan Purba;
2023 Rp. 45,000,000.00 Approved
PENGEMBANGAN SUPLEMEN BAHAN ALAM UNTUK MENINGKATKAN IMUNITAS DAN KAJIAN FARMAKOEKONOMI UNTUK MENINGKATKAN PELAYANAN KEFARMASIAN TERHADAP PASIEN KANKER
Leader : Ajeng Diantini ALG ( ALG )
Personils : Auliya Abdurrohim Suwantika; Yuni Elsa Hadisaputri; Riezki Amalia;
2023 Rp. 100,000,000.00 Approved
ANALISIS EFEKTIVITAS BIAYA PENGOBATAN MENINGITIS TUBERKULOSIS
Leader : Rovina RDDU ( RDDU )
Personils : Auliya Abdurrohim Suwantika;
2023 Rp. 60,000,000.00 Approved
View more ...
Get More with SINTA Insight
Go to Insight

Summary

Article Quartile
Research Output
  Scopus GScholar WOS
Article 83 134 72
Citation 654 1326 486
Cited Document 67 88 50
H-Index 14 22 13
i10-Index 24 45 18
G-Index 1 1 1
Get More with SINTA Insight

Go to Insight